Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin

World Journal of Gastroenterology

Volumn , Issue 26, 2014, Pages 8572-8582

  Liu, Yang Sui ^a   Li, Huan Song ^a   Qi, Dun Feng ^a   Zhang, Jun ^a   Jiang, Xin Chun ^a   Shi, Kui ^a   Zhang, Xiao Jun ^a   Zhang, Xin Hui ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Chemotherapy; Cisplatin; Heme oxygenase 1; Liver cancer cell lines; Zinc protoporphyrin IX

Indexed keywords

BILIRUBIN; CASPASE 3; CISPLATIN; HEME OXYGENASE 1; HEMIN; PROTOPORPHYRIN ZINC; REACTIVE OXYGEN METABOLITE; PORPHYRIN; UNCLASSIFIED DRUG; ZINC PROTOPORPHYRIN IX; ANTINEOPLASTIC AGENT; CASP3 PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CHEMOSENSITIVITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; MTT ASSAY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING; ANTINEOPLASTIC ACTIVITY; DRUG RESISTANCE; ENZYME ACTIVITY; ENZYME INHIBITION; HEPATOMA CELL; LIVER CANCER; LIVER CANCER CELL LINE; TREATMENT RESPONSE; ANIMAL; CARCINOMA, HEPATOCELLULAR; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; HEPG2 CELL LINE; LIVER NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; TIME; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FEMALE; HEME OXYGENASE-1; HEMIN; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE, NUDE; OXIDATIVE STRESS; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904390025     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i26.8572     Document Type: Article

References (33)

1. Bertino G, Di Carlo I, Ardiri A, Calvagno GS, Demma S, Malaguarnera G, Bertino N, Malaguarnera M, Toro A, Malaguarnera M. Systemic therapies in hepatocellular carcinoma: present and future. Future Oncol 2013; 9: 1533-1548 [PMID: 24106903 DOI: 10.2217/fon.13.171]
2. Shin JW, Chung YH. Molecular targeted therapy for hepatocellular carcinoma: current and future. World J Gastroenterol 2013; 19: 6144-6155 [PMID: 24115810 DOI: 10.3748/wjg.v19.i37.6144]
3. Tanaka H, Kubo S, Tsukamoto T, Shuto T, Takemura S, Yamamoto T, Okuda T, Kanazawa A, Hirohashi K. Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria. Transplant Proc 2005; 37: 1254-1256 [PMID: 15848687] (Pubitemid 40590854)
4. Yamamoto S, Sato Y, Takeishi T, Hirano K, Kobayashi T, Watanabe T, Hatakeyama K. Successful surgical treatment for hepatocellular carcinoma and concomitant risky esophageal varices. Hepatogastroenterology 2005; 52: 1083-1086 [PMID: 16001634] (Pubitemid 40942189)
5. Pittalà V, Salerno L, Romeo G, Modica MN, Siracusa MA. A focus on heme oxygenase-1 (HO-1) inhibitors. Curr Med Chem 2013; 20: 3711-3732 [PMID: 23746277]
6. Lin HY, Shen SC, Lin CW, Yang LY, Chen YC. Baicalein inhibition of hydrogen peroxide-induced apoptosis via ROS-dependent heme oxygenase 1 gene expression. Biochim Biophys Acta 2007; 1773: 1073-1086 [PMID: 17532486]
7. Hseu YC, Chou CW, Senthil Kumar KJ, Fu KT, Wang HM, Hsu LS, Kuo YH, Wu CR, Chen SC, Yang HL. Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes. Food Chem Toxicol 2012; 50: 1245-1255 [PMID: 22386815 DOI: 10.1016/j.fct.2012.02.020]
8. Jain K, Suryakumar G, Prasad R, Ganju L. Upregulation of cytoprotective defense mechanisms and hypoxia-responsive proteins imparts tolerance to acute hypobaric hypoxia. High Alt Med Biol 2013; 14: 65-77 [PMID: 23537263 DOI: 10.1089/ham]
9. Guan J, Wu X, Arons E, Christou H. The p38 mitogen-activated protein kinase pathway is involved in the regulation of heme oxygenase-1 by acidic extracellular pH in aortic smooth muscle cells. J Cell Biochem 2008; 105: 1298-1306 [PMID: 18846504 DOI: 10.1002/jcb.21930]
10. Heasman SA, Zaitseva L, Bowles KM, Rushworth SA, Macewan DJ. Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1. Oncotarget 2011; 2: 658-668 [PMID: 21911919]
11. Lin PH, Lan WM, Chau LY. TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation. Oncogene 2013; 32: 2325-2334 [PMID: 22689053 DOI: 10.1038/onc.2012.244]
12. Vashist YK, Uzungolu G, Kutup A, Gebauer F, Koenig A, Deutsch L, Zehler O, Busch P, Kalinin V, Izbicki JR, Yekebas EF. Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer. J Surg Oncol 2011; 104: 305-311 [PMID: 21495030 DOI: 10.1002/jso.21926]
13. Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M, Maeda H. Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 1999; 80: 1945-1954 [PMID: 10471043] (Pubitemid 29391278)
14. Li Y, Su J, DingZhang X, Zhang J, Yoshimoto M, Liu S, Bijian K, Gupta A, Squire JA, Alaoui Jamali MA, Bismar TA. PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome. J Pathol 2011; 224: 90-100 [PMID: 21381033 DOI: 10.1002/path.2855]
15. McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, Früh K, Moses AV. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 2004; 103: 3465-3473 [PMID: 14726403] (Pubitemid 38525679)
16. Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, Wilczynski GM, Głodkowska E, Mrówka P, Issat T, Dulak J, Józkowicz A, Was̈ H, Adamek M, Wrzosek A, Nazarewski S, Makowski M, Stokłosa T, Jakóbisiak M, Gołab J. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006; 25: 3365-3374 [PMID: 16462769] (Pubitemid 43880305)
17. Fang J, Sawa T, Akaike T, Greish K, Maeda H. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer 2004; 109: 1-8 [PMID: 14735461] (Pubitemid 38165358)
18. Kim HJ, So HS, Lee JH, Lee JH, Park C, Park SY, Kim YH, Youn MJ, Kim SJ, Chung SY, Lee KM, Park R. Heme oxygenase-1 attenuates the cisplatin-induced apoptosis of auditory cells via down-regulation of reactive oxygen species generation. Free Radic Biol Med 2006; 40: 1810-1819 [PMID: 16678019]
19. Sass G, Leukel P, Schmitz V, Raskopf E, Ocker M, Neureiter D, Meissnitzer M, Tasika E, Tannapfel A, Tiegs G. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int J Cancer 2008; 123: 1269-1277 [PMID: 18566988 DOI: 10.1002/ijc.23695]
20. Was H, Cichon T, Smolarczyk R, Rudnicka D, Stopa M, Chevalier C, Leger JJ, Lackowska B, Grochot A, Bojkowska K, Ratajska A, Kieda C, Szala S, Dulak J, Jozkowicz A. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 2006; 169: 2181-2198 [PMID: 17148680] (Pubitemid 351181977)
21. Hennig R, Ventura J, Segersvard R, Ward E, Ding XZ, Rao SM, Jovanovic BD, Iwamura T, Talamonti MS, Bell RH, Adrian TE. LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. Neoplasia 2005; 7: 417-425 [PMID: 15967119] (Pubitemid 40664231)
22. Kim HR, Kim S, Kim EJ, Park JH, Yang SH, Jeong ET, Park C, Youn MJ, So HS, Park R. Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin. Lung Cancer 2008; 60: 47-56 [PMID: 18006113] (Pubitemid 351434469)
23. Do MT, Kim HG, Khanal T, Choi JH, Kim DH, Jeong TC, Jeong HG. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways. Toxicol Appl Pharmacol 2013; 271: 229-238 [PMID: 23707609 DOI: 10.1016/j.taap]
24. Mayerhofer M, Gleixner KV, Mayerhofer J, Hoermann G, Jaeger E, Aichberger KJ, Ott RG, Greish K, Nakamura H, Derdak S, Samorapoompichit P, Pickl WF, Sexl V, Esterbauer H, Schwarzinger I, Sillaber C, Maeda H, Valent P. Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood 2008; 111: 2200-2210 [PMID: 18024796] (Pubitemid 351451534)
25. Tibullo D, Barbagallo I, Giallongo C, La Cava P, Parrinello N, Vanella L, Stagno F, Palumbo GA, Li Volti G, Di Raimondo F. Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells. Curr Pharm Des 2013; 19: 2765-2770 [PMID: 23092325]
26. Nuhn P, Künzli BM, Hennig R, Mitkus T, Ramanauskas T, Nobiling R, Meuer SC, Friess H, Berberat PO. Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol Cancer 2009; 8: 37 [PMID: 19508729 DOI: 10.1186/1476-4598-8-37]
27. Lin F, Girotti AW. Hyperresistance of leukemia cells to photodynamic inactivation after long-term exposure to hemin. Cancer Res 1996; 56: 4636-4643 [PMID: 8840977] (Pubitemid 26338063)
28. Hellmuth M, Wetzler C, Nold M, Chang JH, Frank S, Pfeilschifter J, Mühl H. Expression of interleukin-8, heme oxygenase-1 and vascular endothelial growth factor in DLD-1 colon carcinoma cells exposed to pyrrolidine dithiocarbamate. Carcinogenesis 2002; 23: 1273-1279 [PMID: 12151344]
29. Andreadi CK, Howells LM, Atherfold PA, Manson MM. Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol Pharmacol 2006; 69: 1033-1040 [PMID: 16354769] (Pubitemid 43363879)
30. Lee YM, Auh QS, Lee DW, Kim JY, Jung HJ, Lee SH, Kim EC. Involvement of Nrf2-mediated upregulation of heme oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human oral cancer cells. Biomed Res Int 2013; 2013: 210604 [PMID: 23738323 DOI: 10.1155/2013/210604]
31. Liu ZM, Chen GG, Ng EK, Leung WK, Sung JJ, Chung SC. Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 2004; 23: 503-513 [PMID: 14647439] (Pubitemid 38175005)
32. Simizu S, Takada M, Umezawa K, Imoto M. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 1998; 273: 26900-26907 [PMID: 9756937] (Pubitemid 28471710)
33. Banerjee P, Basu A, Datta D, Gasser M, Waaga-Gasser AM, Pal S. The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal. J Biol Chem 2011; 286: 33580-33590 [PMID: 21808062 DOI: 10.1074/jbc.M111.248401]